Technology has made it easier than ever for B2B marketers to reach audiences anywhere. But that global reach hasn’t changed the way many business leaders think about their purchasing decisions.
A public biotechnology company based in Durham is ending its internal drug discovery efforts and closing its primary research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results